We are live on ! Find out more
TC

TwinBeech Capital Portfolio holdings

AUM $965M
1-Year Est. Return 0.23%
This Fund
S&P 500
This Quarter Est. Return
-8.19%
1 Year Est. Return
-0.23%
3 Year Est. Return
-0.53%
5 Year Est. Return
-33.53%
10 Year Est. Return
AUM
$5.21B
AUM Growth
+$140M
Cap. Flow
+$615M
Cap. Flow %
11.81%
Top 10 Hldgs %
12.52%
Holding
954
New
392
Increased
122
Reduced
94
Closed
346

Top Buys

Rank Stock Value
1
DG icon
Dollar General
DG
+$111M
2
HCA icon
HCA Healthcare
HCA
+$72.1M
3
FISV
Fiserv Inc
FISV
+$70.7M
4
DAL icon
Delta Air Lines
DAL
+$64.2M
5
MU icon
Micron Technology
MU
+$63.6M

Sector Composition

Rank Sector Weight
1 Technology 20.47%
2 Healthcare 15.84%
3 Consumer Discretionary 15.42%
4 Industrials 12.94%
5 Financials 11.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NI icon
351
NiSource
NI
$21.9B
$2.96M 0.06%
+119,952
New +$3.24M
AGR
352
DELISTED
Avangrid, Inc.
AGR
$2.89M 0.06%
95,792
+73,588
+331% +$2.6M
LSCC icon
353
Lattice Semiconductor
LSCC
$16.4B
$2.87M 0.06%
+33,433
New +$3.02M
NWSA icon
354
News Corp Class A
NWSA
$15.3B
$2.86M 0.05%
+142,496
New +$2.89M
BBIO icon
355
BridgeBio Pharma
BBIO
$16.8B
$2.83M 0.05%
+107,409
New +$3.05M
SWTX
356
DELISTED
SpringWorks Therapeutics
SWTX
$2.83M 0.05%
+122,429
New +$3.35M
VSAT icon
357
Viasat
VSAT
$10.1B
$2.82M 0.05%
+152,891
New +$4.38M
GES
358
DELISTED
Guess Inc
GES
$2.8M 0.05%
129,181
+92,645
+254% +$1.96M
LSTR icon
359
Landstar System
LSTR
$6.29B
$2.78M 0.05%
+15,728
New +$3.02M
AKRO
360
DELISTED
Akero Therapeutics
AKRO
$2.77M 0.05%
+54,780
New +$2.55M
ENVX icon
361
Enovix
ENVX
$866M
$2.75M 0.05%
+250,832
New +$3.58M
MORF
362
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$2.74M 0.05%
+119,778
New +$6.29M
SNDX icon
363
Syndax Pharmaceuticals
SNDX
$1.74B
$2.73M 0.05%
188,110
+37,914
+25% +$717K
FELE icon
364
Franklin Electric
FELE
$4.85B
$2.69M 0.05%
30,095
+25,076
+500% +$2.43M
SF
365
Stifel
SF
$12.8B
$2.66M 0.05%
64,953
+26,160
+67% +$1.1M
LEG icon
366
Leggett & Platt
LEG
$1.47B
$2.62M 0.05%
103,193
+60,734
+143% +$1.71M
ZNTL icon
367
Zentalis Pharmaceuticals
ZNTL
$329M
$2.58M 0.05%
+128,859
New +$3.27M
ACHC icon
368
Acadia Healthcare
ACHC
$3.01B
$2.58M 0.05%
+36,751
New +$2.75M
FUTU icon
369
Futu Holdings
FUTU
$14.3B
$2.58M 0.05%
+44,578
New +$2.38M
AZEK
370
DELISTED
The AZEK Co
AZEK
$2.57M 0.05%
86,519
-71,801
-45% -$2.26M
SON icon
371
Sonoco
SON
$5.99B
$2.57M 0.05%
47,249
+29,180
+161% +$1.65M
SKYW icon
372
Skywest
SKYW
$4.51B
$2.55M 0.05%
+60,827
New +$2.55M
IART icon
373
Integra LifeSciences
IART
$1.54B
$2.55M 0.05%
66,761
+8,883
+15% +$374K
UA icon
374
Under Armour Class C
UA
$2.97B
$2.55M 0.05%
398,905
-132,152
-25% -$910K
CAH icon
375
Cardinal Health
CAH
$54.5B
$2.54M 0.05%
29,294
-10,249
-26% -$926K

Similar funds

TwinBeech Capital's Q3 2023 Portfolio in Review

As of Q3 2023, TwinBeech Capital held 954 positions worth $5.21B, up 2.8% from $5.07B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

TwinBeech Capital deployed $615M of net new capital in Q3 2023, opening 392 new positions and adding to 122 existing holdings. Its largest new stake was Dollar General: 746,638 shares worth $79M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Fidelity National Information Services, an estimated $62.8M trimmed.

  • TwinBeech Capital's largest Q3 2023 buy was Dollar General: 746,638 shares worth $79M.
  • TwinBeech Capital added most to Edwards Lifesciences in Q3 2023, an estimated $62.6M increase.
  • TwinBeech Capital's biggest Q3 2023 reduction was Fidelity National Information Services, cutting an estimated $62.8M.
  • TwinBeech Capital fully exited PayPal in Q3 2023, selling an estimated $77.2M.
  • TwinBeech Capital's ten largest holdings make up 13% of its $5.21B portfolio in Q3 2023.
  • TwinBeech Capital opened 392 new positions and closed 346 in Q3 2023.
  • TwinBeech Capital's portfolio value rose 2.8% quarter-over-quarter to $5.21B.

Based on TwinBeech Capital's 13F filing for Q3 2023, filed 14 Nov 2023.